Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This Item 5.07 disclosure reports the results of Incyte Corporation's Annual Meeting of Shareholders held on June 8, 2026, including voting outcomes on three matters: election of eight directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core content, making this a textbook shareholder vote results disclosure that is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Ligand Pharmaceuticals held its Annual Meeting of stockholders on June 5, 2026, with shareholders voting on four proposals: election of eight board directors, ratification of Ernst & Young LLP as auditor, advisory vote on named executive officer compensation, and approval of an amended 2002 Stock Incentive Plan. All proposals passed with disclosed vote tallies.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-09
Item 5.02
The Board adopted three new forms of equity award agreements (Performance RSA Agreement, Time-based RSA Agreement, and RSU Award Agreement) under the 2020 LTIP on June 4, 2026, and the Compensation Committee awarded restricted shares to executive officers and directors pursuant to these agreements. This disclosure centers on compensatory arrangements—the establishment of new equity award forms and their grant to named executives and directors—which is the hallmark of Item 5.02(e) compensation disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 7.01
The disclosure announces preliminary assets under management (AUM) for May 31, 2026, which is a key operational metric for an asset management firm like Invesco. While AUM figures are material to investors assessing the company's business performance and competitive position, this does not fit cleanly into the standard earnings_release category (which typically refers to comprehensive quarterly/annual financial results) nor any other specific event type. This is best classified as other_material given its operational significance to the registrant's core business.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-06-09
Item 1.01
Aspira Women's Health entered into a private placement securities purchase agreement on June 5, 2026, issuing 3,300,000 shares of common stock and warrants to purchase 4,455,000 additional shares to accredited and institutional investors for approximately $1.485 million in gross proceeds.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
The filing discloses results of Socket Mobile's June 3, 2026 Annual Meeting of Stockholders under Item 5.07, reporting the election of five directors (Charlie Bass, Kevin J. Mills, Bill Parnell, Ivan Lazarev, and Lynn Zhao), advisory approval of executive compensation with 81.0% affirmative votes, and ratification of Sadler, Gibb & Associates LLC as independent auditors with 99.7% affirmative votes. This is a standard shareholder vote results disclosure material to investors' understanding of corporate governance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-09
Item 1.01
Arch Capital completed a public offering of $2.0 billion in senior notes ($600M due 2036 at 5.250% and $1.4B due 2056 at 5.950%), constituting a material financing transaction and entry into a definitive agreement (Third Supplemental Indenture dated June 9, 2026). This material capital-raising event affects the company's capital structure and financial position.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-09
The 8-K discloses results of Payoneer Global Inc.'s annual meeting of stockholders held on June 9, 2026, including voting outcomes for three proposals: election of Class II directors (John Caplan, Amir Goldman, and Susanna Morgan), ratification of Kesselman & Kesselman as independent auditor, and advisory approval of named executive officer compensation. This is a classic Item 5.07 shareholder vote results disclosure with specific vote tallies for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This Item 5.07 filing discloses the complete results of Apollo Global Management's 2026 Annual Meeting of Stockholders held on June 8, 2026, including voting outcomes for four proposals: election of 13 directors, advisory approval of named executive officer compensation, frequency of say-on-pay votes, and ratification of Deloitte & Touche LLP as independent auditor. The detailed voting tallies (For/Against/Abstain/Broker Non-Votes) for each director nominee and proposal are the core disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 8.01
Rocket Companies disclosed a $1.5 billion private offering of senior notes (6.125% due 2031 and 6.500% due 2034) with proceeds intended to refinance existing debt. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit cleanly into the "dilutive_issuance" category (which typically applies to equity securities or convertible instruments) nor the "ma_activity" category (which covers acquisitions, dispositions, or changes of control). The disclosure of a significant debt refinancing is material to investors but falls outside the more specific event taxonomies.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
The filing discloses financial results for the third fiscal quarter ended May 2, 2026, via a press release furnished as Exhibit 99.1. This is a standard quarterly earnings release under Item 2.02, which is material to investors as it provides the company's periodic financial performance and is central to investment decision-making.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-09
Item 2.02
AITX issued a press release confirming audited fiscal year 2026 results and filing of Form 10-K, disclosing revenue growth and gross margin expansion.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
Item 3.02
The filing discloses unregistered sales of equity securities under Item 3.02, specifically: (1) exercise of 416,667 common stock purchase warrants for $166,667 gross proceeds, with issuance of 416,667 additional incentive warrants; and (2) exercise of 100,000 performance warrants for $100. These transactions are exempt from registration (Regulation S and Rule 506(b)), and the incentive warrants represent dilutive equity issuances. The scale of warrant exercises and the incentive program designed to encourage early exercise of up to 5.7 million outstanding warrants signal material dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-09
Silver Bull disclosed the dismissal of its arbitration claim against Mexico by the ICSID tribunal on May 29, 2026, with the company ordered to pay approximately US$998,000 in Mexico's legal costs. The arbitration arose from Mexico's expropriation of Silver Bull's Sierra Mojada property and represents a material adverse outcome affecting the company's strategic position and financial obligations. This is a material litigation/arbitration settlement outcome that would significantly impact investor assessment of the company's asset base and future prospects.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 7.01
DraftKings disclosed significant month-over-month growth metrics for its Predictions offering (24% consumer volume increase to $1.3B annualized, 34% total volume increase to $3.1B annualized). While these are preliminary operating metrics rather than audited financial results, the substantial growth rates and the company's choice to disclose them via 8-K suggest material business developments. However, the disclosure lacks the formal structure of an earnings release and the company explicitly disclaims materiality, making classification ambiguous between earnings-related disclosure and other material event.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-09
Item 5.02
Jared Oasheim, the Chief Financial Officer, gave notice of his intention to resign on June 7, 2026, to pursue other professional opportunities. While the disclosure includes compensatory arrangements (transition payments, consulting fees, stock option extensions), the principal disclosed action is the CFO's departure. The company is initiating a search for a successor, confirming this is a material executive departure that would affect investor assessment of management continuity and financial oversight.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 35%
filed 2026-06-09
Item 8.01
The filing announces a $1.2 billion private offering of senior notes due 2031 and 2034, offered to qualified institutional buyers under Rule 144A and Regulation S. While this is a material debt issuance, the event is primarily a debt offering rather than an equity issuance. The dilutive_issuance category is typically reserved for unregistered equity sales (PIPEs, convertibles, ATM offerings). This disclosure is more accurately characterized as debt financing activity, which does not fit neatly into the provided taxonomy and may be better classified as other_material.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-09
Item 5.02
Dr. Michael Philip Kimel was appointed as Chief Financial Officer effective June 9, 2026, with a base salary of $350,000 and a pending equity award. Steven Perez was simultaneously appointed as an independent director with $120,000 annual cash compensation. These appointments represent material changes to the registrant's executive and board leadership.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 8.01
Ameriprise Financial issued $750 million in aggregate principal amount of senior notes ($300M due 2031 at 4.800% and $450M due 2036 at 5.350%) on June 9, 2026. While this is a material debt issuance that would affect a reasonable investor's assessment of the company's capital structure and financial obligations, it does not fit cleanly into the more specific event categories. This is a registered public offering of debt securities disclosed under Item 8.01 (Other Events) rather than a covenant breach, dilutive equity issuance, or other enumerated event type.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-09
Item 8.01
The filing discloses a material update on a pending merger: Esperion entered into a Merger Agreement with ArchiMed SAS affiliates on May 1, 2026, and on June 8, 2026, received clearance from the German antitrust authority (Bundeskartellamt). The disclosure explicitly states the Merger remains subject to HSR clearance and stockholder approval at a special meeting scheduled for July 8, 2026. This is a significant M&A milestone that would materially affect investor assessment of the company's future.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-09
Item 1.01
The filing discloses entry into a material definitive agreement for the acquisition of a commercial real property (16,100 sq ft automotive service building in Kansas) for $5.8 million, with closing expected within 45 days. This is a classic Item 1.01 material acquisition event. The Company's plan to assign interests to a Delaware statutory trust and raise capital through a private placement of beneficial interests further confirms the materiality of this transaction to investors assessing the registrant's asset base and capital structure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-09
Item 5.02
The filing discloses an amended and restated employment agreement for Ms. Cindy Lee, the Chief Financial Officer, detailing her base salary ($500,000), discretionary bonus eligibility, a special long-term equity award of 20,000 RSUs vesting over three years, severance provisions including change-of-control protections (2.5x base salary plus bonus), and benefits continuation. This is a material compensatory arrangement for a named executive officer that would affect investor assessment of executive costs and retention incentives.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-09
Item 8.01
The disclosure announces receipt of all regulatory approvals for a merger of Signature Bancorporation into Esquire Financial Holdings. This represents a material acquisition/change of control event—the completion of regulatory approval is a critical milestone in M&A activity that would materially affect investor assessment of the registrant's future operations and financial position.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-09
Item 5.02
Christopher M. Miller (EVP, CFO) departed effective June 26, 2026, and Matthew P. Delly (EVP, Chief Merchandising & Purchasing Officer) departed effective June 12, 2026. These departures of two senior executives represent material changes to the company's management structure and financial leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-09
Item 7.01
Paul Miller was appointed Executive Vice President, Chief Purchasing and Merchandising Officer, effective June 9, 2026, bringing 25 years of tenure with the company in progressively senior roles. This appointment fills a critical C-suite position overseeing merchandising and purchasing functions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
Item 5.02
The filing discloses the appointment of Alexis Black Björlin as a member of the Board of Directors on June 9, 2026. While the section also mentions her compensation arrangement under the 2025 Director Compensation Plan, the principal disclosed action is her appointment to the Board and assignment to the Governance and Sustainability Committee. Board appointments are material events affecting corporate governance and investor assessment of the company.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-09
Item 5.02
Dr. Ranbir Singh resigned from the Board of Directors effective immediately on June 9, 2026, after serving since November 2024. At the time of resignation, he held the position of Chair of the Executive Steering Committee, a senior board role. The filing's reference to his prior Schedule 13D filings (April 23 and May 29, 2026) suggests potential activist involvement or governance concerns, making this departure material to investors' assessment of the company's board composition and control dynamics.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
The filing discloses a press release announcing Cracker Barrel's fiscal 2026 third quarter results of operations and projected outlook for fiscal year 2026, filed under Item 2.02. This is a standard earnings release disclosure, which is material to investors as it provides quarterly financial performance and forward guidance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-09
Item 5.07
Humacyte held its Annual Meeting on June 9, 2026, where stockholders voted on and approved five proposals: election of three Class II directors, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, ratification of PwC as independent auditor, and approval of an amendment to increase authorized common shares from 350 million to 550 million.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder vote results from the June 8, 2026 annual meeting of Franklin BSP Realty Trust, Inc., covering three proposals: election of six directors, ratification of PwC as independent auditor, and an advisory vote on named executive officer compensation. The filing presents detailed voting tallies for each proposal, which is the core content of Item 5.07 disclosures and is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from ClearSign's June 8, 2026 annual meeting. The filing presents detailed voting tallies for five proposals: election of four directors, appointment of auditor BPM CPA LLP, approval of the amended 2021 Equity Incentive Plan, advisory vote on named executive officer compensation, and approval of an adjournment proposal. All proposals passed. This is material as it documents the outcomes of fundamental corporate governance matters including board composition and equity plan authorization.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 8.01
Simon Property Group announced a €500 million debt offering by its subsidiary Simon Global Development B.V., priced at 3.650% due 2031, guaranteed by the parent company. While this is a material financing event affecting the registrant's capital structure and leverage, it does not fit cleanly into the standard taxonomy categories (not M&A, not a restatement, not a covenant breach, etc.). The disclosure is material to investors assessing the company's financial position and debt obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Shareholders voted at the Company's Annual Meeting on June 9, 2026, approving five proposals: election of five directors, ratification of BDO USA P.C. as auditor, approval of the 2026 Omnibus Incentive Plan, an advisory vote on named executive officer compensation, and an advisory vote on compensation vote frequency.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of an annual meeting of stockholders held on June 3, 2026. The filing presents voting results for two proposals: (1) election of Class II directors (Sashi Brown and Jamila Mayfield, each receiving 21,530,729 votes for and 0 against), and (2) ratification of Ernst & Young LLP as independent auditor (21,530,729 for, 0 against, 1,138,021 abstentions). Director elections and auditor ratifications are material governance matters affecting investor assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-09
Item 4.01
Vireo Growth Inc. dismissed Davidson & Company LLP as its independent registered public accounting firm effective June 5, 2026, and concurrently appointed BDO USA, P.C. as the new auditor. The filing indicates no disagreements or reportable events in connection with the transition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder voting results from the June 5, 2026 Annual Meeting of Stockholders, filed under Item 5.07. The filing presents final voting tallies for four proposals: election of six directors, ratification of Deloitte and Touche LLP as auditor, advisory approval of named executive officer compensation, and amendment to the 2018 Omnibus Equity Incentive Plan. All proposals were approved. This is a material event as it reflects stockholder decisions on governance, auditor selection, and equity plan authorization.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Ulta Beauty held its Annual Meeting of Stockholders on June 9, 2026, with shareholders voting on six proposals: election of ten directors, approval of exculpation and forum selection amendments to the certificate of incorporation, ratification of Ernst & Young LLP as auditor, an advisory vote on executive compensation, and approval of the 2026 Incentive Award Plan.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-06-09
Item 5.02
Stockholders approved the 2026 Incentive Award Plan, which replaces the prior equity compensation plan and authorizes 5,001,201 shares for future grants of stock options, RSUs, restricted stock, and other equity awards to employees, consultants, and directors.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 8.01
Eagle Point Income Company Inc. disclosed management's unaudited estimate of net asset value (NAV) per share as of May 31, 2026, ranging from $12.52 to $12.62. For a closed-end investment company, NAV disclosure is material to investors assessing the fund's value and performance, though this appears to be a routine periodic NAV estimate rather than a discrete material event. Classified as other_material because NAV disclosure does not fit the more specific event categories, but it is material to shareholders of an income-focused investment company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
Item 5.02
The filing discloses the appointment of Donna T. Guerra to the Board of Directors of Fifth District Bancorp, Inc. and its bank subsidiary effective June 8, 2026. The principal action is a person taking a director role, with detailed background information provided on her qualifications, including prior CFO and COO experience at Hibernia Bank. Board appointments are material events affecting corporate governance and investor assessment of the company.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 8.01
Eagle Point Credit Co disclosed management's unaudited estimate of net asset value (NAV) per share as of May 31, 2026, ranging from $4.55 to $4.65. For a closed-end credit company, NAV is a key metric affecting investor valuation and pricing decisions. While this appears to be a routine periodic NAV disclosure under Item 8.01, it is material to shareholders as it directly informs the fair value of their holdings. This does not fit neatly into other specific event categories but warrants classification as material disclosure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-06-09
Item 5.02
Stephen M. Cook, a Class II director and Chair of the Nominating and Corporate Governance Committee, notified the Board that he will not stand for re-election at the 2026 Annual Meeting, with his retirement effective upon expiration of his current term.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-09
Item 8.01
The Board unanimously approved Todd C. Harvey as a new Class II director nominee for the 2026 Annual Meeting, subject to stockholder election, representing a material change in board composition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-09
Item 1.01
Hut 8 Corp., through its wholly-owned subsidiary Beacon Point DC LLC, completed a $4.25 billion senior secured notes offering on June 9, 2026, with proceeds earmarked to finance a 352 MW data center facility in Texas to be leased to a high-investment-grade tenant. This material capital structure event and significant operational commitment affects the company's financial position and strategic direction.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 8.01
The Board approved a $40 million stock repurchase program on May 13, 2026, which is a material capital allocation decision affecting shareholder value and the company's financial strategy. While share repurchases are common corporate actions, a $40 million authorization is material to investors assessing capital deployment and future earnings per share impacts. This does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or impairment), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 7.01
Cartesian Therapeutics disclosed entry into a strategic licensing agreement with WestGene Biopharma for development of novel in vivo CAR-T therapies in autoimmune diseases. While this is a material partnership/licensing arrangement that could affect the company's pipeline and strategic direction, it does not fit cleanly into the M&A taxonomy (which focuses on acquisitions, dispositions, mergers, or changes of control). The licensing agreement is a material collaboration event that a reasonable investor would want to know about, but lacks the acquisition/merger/control-change characteristics of ma_activity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-09
Item 1.01
This disclosure concerns an amendment to a previously announced merger agreement between Lisata Therapeutics and Kuva Labs Inc., extending key deadlines (tender offer commencement from June 1 to June 10, 2026, and the Outside Date from July 1 to July 17, 2026) and modifying payment obligations and waivers. The amendment directly relates to the ongoing merger transaction and materially affects its timing and conditions, making it a material M&A activity event under Item 1.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-09
Item 7.01
Allegiant Travel completed the acquisition of Sun Country Airlines Holdings, Inc., financed in part through approximately $224.7 million in aircraft financing transactions completed between April and May 2026. Pro forma financial information reflecting the combined entity's capital structure and financial position was disclosed.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-09
Item 8.01
Allegiant Travel commenced a $500 million private offering of senior secured notes due 2031 to qualified institutional buyers under Rule 144A and Regulation S, concurrent with a tender offer for $403 million of existing 2027 notes.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 85%
filed 2026-06-09
Item 8.01
The disclosure reports that CarParts.com has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5450(a)(1)) after the closing bid price remained at $1.00 or greater for 10 consecutive business days. This is a delisting-risk event because it documents resolution of a prior non-compliance notice that threatened continued listing. The materiality is high because listing status directly affects investor access and trading liquidity.
View raw filing on EDGAR →